Which pharmaceutical product development breakthrough was the first FDA-approved monoclonal antibody treatment for cancer?

The development of new medical products often involves extensive clinical trials and breakthrough technologies. This poll tests your knowledge about a significant medical product development milestone that changed treatment paradigms. Understanding these pivotal moments in medical product history showcases how innovation transforms healthcare delivery and patient outcomes. Test your knowledge about this revolutionary medical advancement!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Rituximab (Rituxan) - approved in 1997 for non-Hodgkin's lymphoma
Trastuzumab (Herceptin) - approved in 1998 for breast cancer
Bevacizumab (Avastin) - approved in 2004 for colorectal cancer
Adalimumab (Humira) - approved in 2002 for rheumatoid arthritis